Articles published by Can-Fite BioPharma Ltd.
Via GlobeNewswire
Can-Fite Provides Namodenoson Patent Update
July 29, 2024
Via GlobeNewswire
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite Reports 2023 Financial Results and Clinical Update
March 28, 2024
Via Business Wire
Tickers
CANF
Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada
February 28, 2024
Via Business Wire
Tickers
CANF
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
January 30, 2024
Via Business Wire
Tickers
CANF
Can-Fite: Top Scientific Journal Published Positive Data from the COMFORT-1 Phase III Psoriasis Study
January 29, 2024
Via Business Wire
Tickers
CANF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.